Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Frattamaggiore – page 2

20 clinical trials in Frattamaggiore, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Frattamaggiore at a glance
20
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

20 trials in Frattamaggiore

Open in trial search

Hepatocellular carcinoma

Not yet recruiting

Advanced hepatocellular carcinoma patients: assessing atezolizumab drug combination and other treatment sequences

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab

Prostate cancer

Not yet recruiting

Study on Docetaxel and Carboplatin-Docetaxel Combination for Prostate Cancer Patients Progressing After Olaparib Treatment

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Azienda Provinciale Per I Servizi Sanitari

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.

Study on Pembrolizumab for Patients with Resectable Metastases from Kidney Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Consorzio Oncotech

Study of drug combination with gemcitabine, cisplatin, carboplatin and avelumab in patients with advanced urothelial cancer to evaluate response to platinum-based chemotherapy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Janssen Cilag International

Study of TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Not Undergoing Radical Cystectomy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cetrelimab
  • Sponsor:Janssen Cilag International

Study of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Seagen Inc.

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Frattamaggiore

What the registry says about research in the country

01 Oncology - Breast Cancer

Studies focusing on hormone receptor-positive breast cancer treatments, evaluating novel therapeutic approaches for patients with advanced disease. Research includes assessment of targeted therapies and hormone-based treatments.

  • Advanced treatment strategies for HER2-negative breast cancer
  • Hormone therapy resistance management
  • CDK4/6 inhibitor combinations
02 Oncology - Colorectal Cancer

Investigation of treatments for metastatic colorectal cancer, particularly focusing on patients with specific genetic profiles. Studies evaluate combination therapies and treatment scheduling approaches.

  • RAS/BRAF wild-type targeted therapies
  • First-line treatment optimization
  • Immunotherapy combinations
03 Oncology - Urological Cancers

Research on urothelial carcinoma and prostate cancer, exploring innovative treatment combinations and targeted therapies. Studies assess both early-stage and advanced disease management.

  • Advanced prostate cancer treatments
  • Bladder cancer therapy
  • Combination immunotherapy approaches
04 Neurological Conditions

Clinical research addressing acute cerebral hemorrhage management, with focus on improving patient outcomes through early intervention strategies.

  • Stroke treatment
  • Emergency medicine protocols
  • Hemorrhage management
05 Addiction Medicine

Studies evaluating treatments for alcohol dependence, focusing on reducing consumption and maintaining abstinence in high-risk populations.

  • Alcohol consumption reduction
  • Treatment of addiction
  • Risk level management
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.